Robert Zanni

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: Results from the palivizumab outcomes registry

Curt Parnes, Judith Guillermin, Rolf Habersang et al. · Pediatric Pulmonology · 2003 · 122 citations

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 116 citations · Full text

Medicine, Hypertonic Saline, Dornase Alfa +1

Azithromycin for Early <i>Pseudomonas</i> Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial

Nicole Mayer-Hamblett, George Retsch‐Bogart, Margaret Kloster et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 96 citations · Full text

Vitamin D deficiency is associated with pulmonary dysfunction in cystic fibrosis

William Sexauer, Anas Hadeh, Pamela Ohman‐Strickland et al. · Journal of Cystic Fibrosis · 2015 · 87 citations

Fibrosis, Pathology, Pulmonary Fibrosis +5

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function

Wayne J. Morgan, Donald R. VanDevanter, David J. Pasta et al. · The Journal of Pediatrics · 2015 · 59 citations

Advanced Lung Disease, Forced Expiratory Volume, Pulmonary Physiology +6